MS-347a, A new inhibitor of myosin light chain kinase from aspergillus sp. ky52178

14Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

MS-347a was isolated from the culture broths of Aspergillus sp. KY52178 as an inhibitor of smooth muscle myosin light chain kinase (MLCK). MS-347a inhibited the activity of chicken gizzard MLCK with an IC50 value of 9.2μM. The inhibition was dependent on time of preincubation of MS-347a with the enzyme, suggesting irreversible inhibition. It is likely that the inhibitor binds to the catalytic domain of MLCK, since the compound inhibited not only calmodulin-dependent but also calmodulin-independent activity of MLCK. Calmodulin-dependent cyclic nucleotide phospho diesterase, cAMP-dependent protein kinase and cGMP-dependent protein kinase were not inhibited by 150μm MS-347a at all, although the compound inhibited protein kinase C with an IC50 value of 16μm. MS-347b, a minor component was also isolated from the same culture broths. This minor component at 150 μm did not inhibit the activity of MLCK. © 1993, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Nakanishi, S., Ando, K., Kawamoto, I., & Matsuda, Y. (1993). MS-347a, A new inhibitor of myosin light chain kinase from aspergillus sp. ky52178. Journal of Antibiotics, 46(12), 1775–1781. https://doi.org/10.7164/antibiotics.46.1775

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free